Arlington Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by Arlington Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Arlington Capital Management from 13F filings

Historical chart of Arlington Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Arlington Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Arlington Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $363k 800 453.36
2015-06-30 $3.8M 31k 124.10
2015-03-31 $3.3M 28k 117.97
2014-12-31 $3.0M 26k 118.81

More positions owned by Arlington Capital Management

Ishares Gold Tr Ishares New (IAU)
NVIDIA Corporation (NVDA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Gold Miners Etf (GDX)
Ishares Tr Msci Poland Etf (EPOL)
Ishares Msci Austria Etf (EWO)
Ishares Msci Spain Etf (EWP)
First Tr Exch Trd Alphdx Germany Alpha (FGM)
Global X Fds Msci Greece Etf (GREK)
Ishares Tr Msci Euro Fl Etf (EUFN)
New Gold Inc Cda (NGD)
Anglogold Ashanti Com Shs (AU)
Banco Santander Sa Adr (SAN)
Sibanye Stillwater Sponsored Adr (SBSW)
Banco Bilbao Vizcaya Argenta Sponsored Adr (BBVA)

View all positions for Arlington Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
FMR
Ubs Global Asset Management Americas
ClearBridge Advisors

View all funds holding Vertex Pharmaceuticals Incorporated